Back
Corcept Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
CORT
Corcept Therapeutics
Last Price:
$58.65
Seasonality Move:
2.99%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corcept Therapeutics Stock Forecast
-
Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 36.7% based on the past 20 years of stock performance.
-
Corcept Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Corcept Therapeutics Stock Undervalued?The current Corcept Therapeutics [CORT] share price is $58.66. The Score for CORT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 36.7% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
58
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
-
Corcept Therapeutics has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
75.00
52-Week Low:
20.84
Prediction Charts
Market Cap:
6.2B
Price in USD:
58.66
Volume:
1.9M
Beta:
0.89
Technical Analysis
SMA50:
60.65
SMA100:
57.42
SMA200:
46.86
52-Wk Change:
137.01%
Stock Predictions
-
Is Corcept Therapeutics stock public?Yes, Corcept Therapeutics is a publicly traded company.
-
What is the Corcept Therapeutics stock quote today?The Corcept Therapeutics stock price is 58.66 USD today.
-
How to buy Corcept Therapeutics stock online?You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-3 | 61.39 | 59.10 | 61.39 | 57.82 |
| Mar-4 | 58.72 | 55.99 | 60.32 | 55.80 |
| Mar-5 | 56.02 | 55.49 | 57.11 | 54.66 |
| Mar-6 | 54.37 | 54.28 | 56.11 | 53.82 |
| Mar-7 | 54.16 | 55.40 | 56.18 | 52.45 |
| Mar-11 | 56.57 | 55.42 | 57.56 | 55.04 |
| Mar-12 | 57.47 | 55.00 | 57.95 | 54.40 |
| Mar-13 | 55.29 | 54.85 | 55.55 | 54.18 |
| Mar-14 | 55.51 | 56.01 | 56.83 | 54.12 |
| Mar-17 | 55.01 | 57.88 | 58.48 | 55.01 |
| Mar-18 | 57.45 | 56.50 | 57.88 | 56.10 |
| Mar-19 | 56.07 | 58.00 | 58.61 | 55.64 |
| Mar-20 | 57.32 | 57.59 | 59.72 | 57.02 |
| Mar-21 | 56.74 | 58.66 | 59.14 | 56.33 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $1.63 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.